Nippon logo

Nippon India Pharma Fund (G)

Equity · Sectoral

11.76%

Last 1 year

Exit Load
1.00%
Expense Ratio
1.83%
Min. AmountMin. SIP Amount
₹100
Min. Lump SumMin. Lump sum
₹5,000

Historical View

This fund9.9%
vs
Nifty5010.3%

Return Calculator

Investment Type
Monthly Investment

Slide to choose

₹100₹1 L
Investment Period

Slide to choose

1 Yr5 Yr
Invested Amount
₹9,00,000
Calculated AmountCurrent Value
₹11,70,990
IRR
16.532%
Absolute Gain
+₹2,70,990 (+30.1%)

Returns & Rankings

Category: Equity Sectoral

Kotak Mahindra logoHDFC logoSBI logo63 Products
1Y3Y5YAll
Fund returns11.8%16.5%13.8%19.8%
Category average6.9%14.6%11.6%NA
Rank with in category17/5513/387/29NA

Equity Sectoral Funds

Kotak Mahindra logoHDFC logoSBI logo63 Products
3 Yr Return
Fund Returns16.5%
Category Average14.6%
Rank with in Category13 out of 38

Wealthy Score

Return Score rates how well the fund has rewarded investors over time, comparing its returns across periods with other funds in its category.

1Y Returns
11.8%
3Y Returns
16.5%
5Y Returns
13.8%
Alpha
11.47

Holding Analysis

Equity/Debt/Cash Split

  • Equity99.6%
  • Debt0.4%
  • Equity
    99.6%
  • Debt
    0.4%

Market Cap Weightage

  • Mid Cap49%
  • Large Cap29.5%
  • Small Cap21.1%
  • Others0.4%
  • Mid Cap
    49%
  • Large Cap
    29.5%
  • Small Cap
    21.1%
  • Others
    0.4%

Sector allocation

  • Healthcare97.4%
  • Consumer Discretionary2.3%
  • Debt0.4%
  • Healthcare
    97.4%
  • Consumer Discretionary
    2.3%
  • Debt
    0.4%

Top 10 HoldingsTop Holdings

StocksSectorPercentage
Sun Pharma.Inds.Pharmaceuticals11.55%
Divi's Lab.Pharmaceuticals6.73%
CiplaPharmaceuticals6.21%
LupinPharmaceuticals6.16%
Dr Reddy's LabsPharmaceuticals6.13%
Apollo HospitalsHealthcare5.1%
Mankind PharmaPharmaceuticals4.4%
Sai LifePharmaceuticals4.04%
Ajanta PharmaPharmaceuticals3.53%
Max HealthcareHealthcare3.31%
StocksPercentage
  • Sun Pharma.Inds.

    Pharmaceuticals

    11.55%
  • Divi's Lab.

    Pharmaceuticals

    6.73%
  • Cipla

    Pharmaceuticals

    6.21%
  • Lupin

    Pharmaceuticals

    6.16%
  • Dr Reddy's Labs

    Pharmaceuticals

    6.13%

Peer Comparison

Nippon India Pharma Fund (G)

1 Y Return
11.76%
3 Y Return
16.53%
5 Y Return
13.75%

Nifty 50

1 Y Return
-2.32%
3 Y Return
9.41%
5 Y Return
8.00%

Investment Objective

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

Fund Management

  • Sailesh Raj Bhan

    Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Riskometer

Risk Score
6
Risk Level
Very High

Advanced Ratios

AlphaReturn earned over the benchmark after adjusting for risk. Higher is better.
11.47
BetaHow much the fund moves with the market. Above 1 means more volatile than the market.
0.65
SRSharpe Ratio: return earned per unit of total risk taken. Higher is better.
0.78
SDStandard Deviation: how much returns swing around their average. Lower means steadier returns.
14.85
TRTreynor Ratio: return earned per unit of market risk (beta). Higher is better.
0.03
P/EPrice to Earnings of the stocks the fund holds. Higher means a pricier portfolio.
43.73

Tax Implication

STCG Tax: 20% if redeemed before 1 Year. LTCG Tax: 12.5% exceeding Rs. 1,25,000/- post 1 Year

Invest in Mutual Funds?

Start a SIP or lump sum in minutes, with zero paperwork.

wealthy

Download the Wealthy Appto enjoy efficient Trading and Investing!

Download App QR Code
google-playapp-store

Welcome to Wealthy

user
mobile
OR
google-playapp-store
Curated Investing
Curated Investing
Completely Digitalised
Completely Digitalised
Bank Grade Security
Bank Grade Security
Help Centers
Help Centers

FAQs